CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
84 hedge funds and large institutions have $1.28B invested in CureVac in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 11 closing their positions.
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
209% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 11
54% more capital invested
Capital invested by funds: $834M → $1.28B (+$450M)
38% more funds holding
Funds holding: 61 → 84 (+23)
1.68% more ownership
Funds ownership: 5.83% → 7.52% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less call options, than puts
Call options by funds: $114M | Put options by funds: $132M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$99.8M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$47.6M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$36.1M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33.9M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$6.76M |
| 2 |
Jane Street
New York
|
-$5.31M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$4.15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.39M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.09M |
CVAC Hedge Fund Activity: Q1 2021 in Review
84 of the 5,627 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q1 2021, worth a combined $1.28B — up 54% from $834M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CVAC positions and 11 closed out — a net gain of 23 holders — while 29 added to existing stakes and 9 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $99.8M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $6.76M sold.
- 84 institutional investors held CureVac (CVAC) as of Q1 2021, up from 61 in Q4 2020.
- Funds reported $1.28B of CureVac stock for Q1 2021, up 54% quarter-over-quarter.
- 34 funds opened new CureVac positions in Q1 2021 and 11 closed out, a net change of +23 holders.
- The largest CureVac buyer in Q1 2021 was Baillie Gifford & Co, an estimated $99.8M added.
- The largest CureVac seller in Q1 2021 was D.E. Shaw & Co, an estimated $6.76M sold.
Based on aggregated 13F filings for Q1 2021.